News

Saint Luke's Rehabilitation Institute's newest staff member is making an immediate impact on patient care this year. Henli is a two-year old facility dog, highly trained to work in clinical settings alongside licensed therapists.

Dana Boucher found relief with LUTATHERA, a targeted radioactive therapy specifically for neuroendocrine tumors (NETs) found in the gut or pancreas.

In 2023, an emergency colonoscopy led to Michael's diagnosis of stage 3 cancer. Because of his experience, Michael Kathrens, 70, advocates for proactive health screenings and being an advocate for your own health.

A new study co-led by a Saint Luke's researcher found that it may be possible to safely cut back on the level of monitoring of patients with stroke after thrombolysis administration.

Nellie Jo Gaston received a lifesaving surgery after an abnormal result from an at-home colon cancer screening test. After treatment at Saint Luke’s, she is cancer-free.

During Stroke Awareness Month, Karin Olds, MD, stroke medical director at Saint Luke's Marion Bloch Neuroscience Institute, joined KMBC to discuss stroke risk factors and warning signs in younger adults.

The annual event offers a unique form of therapy that allows patients to build skills and confidence in everyday tasks they love.

Two years after an intern presented on the clinical and emotional benefits of service animals, the Rehabilitation Institute is delighted to introduce the world to Henli, a highly trained dog with a knack for comfort and connection.

Dr. Karin Olds, stroke director for Saint Luke's Marion Bloch Neuroscience Institute, joined KCTV to discuss the leading cause of long-term disability.

Weeks shy of the bar exam, the trajectory of Jackson’s life was rocked off course when he was diagnosed with stage 3 colon cancer. The 26-year-old’s diagnosis was an obstacle that he refused to let topple him.